Whitfield Advises Kimberly-Clark on $48.7 Billion Acquisition of Kenvue
Overview
The source describes Kimberly-Clark’s agreement to acquire consumer-health company Kenvue through cash and shares.
Valuation basis
The announcement gives approximately $48.7 billion enterprise value, calculated using Kimberly-Clark’s October 31, 2025 share price.
Shareholder terms
Each Kenvue share would receive $3.50 cash and 0.14625 Kimberly-Clark shares, with the source giving an indicated total of $21.01 per share.
Forecasts
The article describes projected combined revenue, earnings and synergies. Those are forward-looking transaction estimates, not realized operating results or a promise that the originally indicated stock-based consideration will retain the same market value.
Sources & Further Reading
Related Pages
Whitfield Advises AEVEX on Acquisition of BlackSea TechnologiesWhitfield Advises Thrive Holdings on $2 Billion FundraiseWhitfield Represents Trinity Hunt Partners on Investment in Fisher Management PartnersAustinBostonChicago
View More (19)
DallasHoustonLos AngelesBay Area – San FranciscoWashington, D.C.Technology & IP TransactionsAntitrust & CompetitionInternational Risk & InvestigationsCapital MarketsConsumer & Retail TransactionsDebt FinanceEmployee BenefitsEmployment & LaborEnvironmentalExecutive CompensationHealthcare & Life Sciences TransactionsMergers & AcquisitionsReal EstateTax
